Bios Equity Partners, LP - 20 Feb 2026 SCHEDULE 13D/A Report for Lantern Pharma Inc. Common Stock, par value $0.0001 per share (LTRN)

Filing Manager
Bios Equity Partners, LP
Reporting Manager
BIOS CAPITAL MANAGEMENT, LP
Security
Lantern Pharma Inc. Common Stock, par value $0.0001 per share
Symbol
LTRN
Shares outstanding
11,189,114 shares
Disclosed Ownership
960,026 shares
Ownership
8.6%
Form type
SCHEDULE 13D/A
Filing time
23 Feb 2026, 16:37:09 UTC
Date of event
20 Feb 2026
Previous filing
13 Jun 2025
Next filing
16 Apr 2026
SEC
View on sec.gov

Quoteable Key Fact

"Bios Equity Partners, LP disclosed 8.6% ownership in Lantern Pharma Inc. Common Stock, par value $0.0001 per share (LTRN) on 20 Feb 2026."

Quick Takeaways

  • Bios Equity Partners, LP filed SCHEDULE 13D/A for Lantern Pharma Inc. Common Stock, par value $0.0001 per share (LTRN).
  • Disclosed ownership: 8.6%.
  • Date of event: 20 Feb 2026.

What Changed

  • Previous schedule filing date: 13 Jun 2025.
  • Current filing was accepted on 23 Feb 2026, 16:37.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (14)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Bios Fund I, LP 2.6% 287,619 0 287,619 /s/ John Fucci John Fucci/Attorney-in-Fact 0001697316
BIOS EQUITY PARTNERS II, LP 4.3% 478,079 0 478,079 /s/ John Fucci John Fucci/Attorney-in-Fact 0001813313
BIOS FUND I QP, LP 1.5% 168,235 0 168,235 /s/ John Fucci John Fucci/Attorney-in-Fact 0001700297
BIOS FUND II, LP 0.91% 101,665 0 101,665 /s/ John Fucci John Fucci/Attorney-in-Fact 0001714576
BIOS FUND II QP, LP 3% 331,974 0 331,974 /s/ John Fucci John Fucci/Attorney-in-Fact 0001716869
BIOS FUND II NT, LP 0.4% 44,440 0 44,440 /s/ John Fucci John Fucci/Attorney-in-Fact 0001728851
BP DIRECTORS, LP 0.23% 26,093 0 26,093 /s/ John Fucci John Fucci/Attorney-in-Fact 0001813311
BIOS EQUITY PARTNERS, LP 4.3% 481,947 0 481,947 /s/ John Fucci John Fucci/Attorney-in-Fact 0001813314
BIOS CAPITAL MANAGEMENT, LP 8.6% 960,026 0 960,026 /s/ John Fucci John Fucci/Attorney-in-Fact 0001813845
BIOS ADVISORS GP, LLC 8.6% 960,026 0 960,026 /s/ John Fucci John Fucci/Attorney-in-Fact 0001813844
CAVU MANAGEMENT, LP 8.6% 960,026 0 960,026 /s/ John Fucci John Fucci/Attorney-in-Fact 0001813270
CAVU ADVISORS, LLC 8.6% 960,026 0 960,026 /s/ John Fucci John Fucci/Attorney-in-Fact 0001813310
LESLIE W. KREIS 8.6% 960,026 0 960,026 /s/ John Fucci John Fucci, as Attorney-in-Fact for Leslie W. Kreis, Jr. 0001813316
AARON G.L. FLETCHER 8.6% 960,026 0 960,026 /s/ John Fucci John Fucci, as Attorney-in-Fact for Aaron G.L. Fletcher 0001789490